in collaboration with BASL and BVHG

Topics include:

• HCV mono-infection: when to treat and when to wait
• HIV/HCV co-infection: when to treat and when to wait
• Pathogenesis of liver disease in HBV infection
• Treating hepatitis C in patients with chronic renal disease
• What's in the pipeline?
• HIV-1-positive patients co-infected with hepatitis C should be excluded from liver transplant programmes
• The impact of viral resistance in the management of HCV with DAAs
• Drug–drug interactions with new HCV drugs
• Difficult HIV/hepatitis co-infection SpR case presentation session

• Draft programme / registration form  [ 320 kb ]